These tumors exhibit elevated c-MYC expression, and the authors used CDK1 siRNA delivered by cationic lipid assisted nanoparticles to induce decreased cell viability and apoptosis only in c-MYC overexpressed triple-negative breast cancers and not in normal mammary epithelial cells. Here, CDK1 is linked to triple-negative breast carcinoma.